Literature DB >> 2868771

Effects of a long-acting somatostatin analogue in patients with severe ileostomy diarrhoea.

J C Cooper, N S Williams, R F King, M C Barker.   

Abstract

Proctocolectomy (PC) with small bowel resection may lead to profuse ileostomy diarrhoea which can be difficult to treat. The effect of a recently developed long acting somatostatin analogue (SMS 201-995) on ileostomy output was investigated in 5 patients who had undergone PC and ileal resection (median 120 cm) and who suffered severe diarrhoea (4-7 litres/24 h). Gastric emptying, transit of a standard meal through the small bowel and the amounts of nutrients excreted were simultaneously determined during double blind infusion of SMS (25 micrograms/h) and placebo (isotonic saline 125 ml/h). SMS 201-995 significantly reduced ileostomy output (P less than 0.05) and water excretion (P less than 0.05) and prolonged small bowel transit time (P less than 0.05). Whilst having little effect on gastric emptying, or on the excretion of glucose or nitrogen, fat excretion was significantly increased (P less than 0.05). In two patients subcutaneous administration of SMS 201-995 (50 micrograms b.d.) has maintained a reduced ileostomy output for 4 and 6 months respectively.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2868771     DOI: 10.1002/bjs.1800730219

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  17 in total

1.  Guidelines for management of patients with a short bowel.

Authors:  J Nightingale; J M Woodward
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

Review 2.  Ileostomy diarrhea: Pathophysiology and management.

Authors:  Kyle M Rowe; Lawrence R Schiller
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-01-30

Review 3.  Management of patients with a short bowel.

Authors:  J M Nightingale
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

4.  The adverse effects of octreotide on the healing of colonic anastomoses in rats.

Authors:  A G Türkçapar; S Demirer; N Sengül; S Ersöz; E Kuterdem; N Renda; I Kuzu
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

5.  Ileostomy diarrhea.

Authors:  Andrew W DuPont; Joseph H Sellin
Journal:  Curr Treat Options Gastroenterol       Date:  2006-02

6.  Effect of somatostatin analog (SMS 201-995) on in vivo intestinal fluid transport in rats. A limited systemic effect.

Authors:  R N Fedorak; S L Allen
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

Review 7.  Octreotide in the treatment of refractory diarrhoea and intestinal fistulae.

Authors:  M J Farthing
Journal:  Gut       Date:  1994       Impact factor: 23.059

8.  Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA.

Authors:  James A Martenson; Michele Y Halyard; Jeff A Sloan; Gary M Proulx; Robert C Miller; Richard L Deming; Stephen J Dick; Harold A Johnson; T H Patricia Tai; Angela W Zhu; Joan Keit; Kathy J Stien; Pamela J Atherton
Journal:  J Clin Oncol       Date:  2008-09-02       Impact factor: 44.544

9.  Octreotide effectively decreases mucosal damage in experimental colitis.

Authors:  R Eliakim; F Karmeli; E Okon; D Rachmilewitz
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

10.  Reduction of the effluent volume in high-output ileostomy patients by a somatostatin analogue, SMS 201-995.

Authors:  K Kusuhara; M Kusunoki; T Okamoto; Y Sakanoue; J Utsunomiya
Journal:  Int J Colorectal Dis       Date:  1992-12       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.